Product pharmaceutical-intermediates-nuclide-drug

Catalog	name	Description	price
R-M2-10083	Lu-177-PSMA-617	177Lu-PSMA-617 is a radioligand therapy for targeted treatment of prostate cancer, which precisely kills cancer cells by labeling PSMA antigens with beta rays, especially suitable for patients with metastatic castration resistant prostate cancer (mCRPC). Clinical studies have shown that this therapy can significantly prolong patient survival and reduce PSA levels, and suitable patients need to be screened through PSMA PET/CT screening. Multidisciplinary diagnosis and treatment centers have been established domestically to promote standardized application. This product is only for scientific research and cannot be used on the human body.	price>
R-M2-10084	Ga-68-PSMA-I&T	Ga-68-PSMA-I&T is a molecular probe used for the diagnosis of prostate cancer, which achieves precise imaging by targeting prostate-specific membrane antigen (PSMA).	price>
R-M2-10085	Ga-68-PSMA-11	68Ga-PSMA-11 is a radiopharmaceutical used for the diagnosis of prostate cancer, achieving high-sensitivity imaging through targeted binding to prostate-specific membrane antigen (PSMA).	price>